Cargando…
Brain Insulin Resistance and Deficiency as Therapeutic Targets in Alzheimer's Disease
Alzheimer's disease [AD] is the most common cause of dementia in North America. Despite 30+ years of intense investigation, the field lacks consensus regarding the etiology and pathogenesis of sporadic AD, and therefore we still do not know the best strategies for treating and preventing this d...
Autor principal: | de la Monte, Suzanne M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Bentham Science Publishers
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3349985/ https://www.ncbi.nlm.nih.gov/pubmed/22329651 http://dx.doi.org/10.2174/156720512799015037 |
Ejemplares similares
-
CSF and Brain Indices of Insulin Resistance, Oxidative Stress and Neuro-Inflammation in Early versus Late Alzheimer’s Disease
por: Lee, Sarah, et al.
Publicado: (2013) -
Insulin resistance in the brain: A new therapeutic target for Alzheimer's disease
por: Umegaki, Hiroyuki
Publicado: (2013) -
Brain insulin resistance in Alzheimer’s disease
Publicado: (2012) -
Inflammation and Insulin Resistance as Risk Factors and Potential Therapeutic Targets for Alzheimer’s Disease
por: Vinuesa, Angeles, et al.
Publicado: (2021) -
Dysregulation of Insulin-Linked Metabolic Pathways in Alzheimer’s Disease: Co-Factor Role of Apolipoprotein E ɛ4
por: Robbins, James, et al.
Publicado: (2020)